General Information of This Antibody
Antibody ID
ANI0GJJSU
Antibody Name
Anti-IL13RA2 PF-06473811 mAb
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized IgG
Antigen Name
Interleukin-13 receptor subunit alpha-2 (IL13RA2)
 Antigen Info 
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
Anti-IL13RA2-ADC [Investigative]
Discovered Using Cell Line-derived Xenograft Model
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Tumor Growth Inhibition value (TGI) ≈ 29.60% (Day 13) High IL13RA2 expression (IL13RA2+++)
Method Description
2 x106 A375 cells in 50% Cultrex basement membrane extract were injected subcutaneously in the flank of athymic nu/nu mice for FMT imaging or in the upper right shoulder for PET/CT imaging.
In Vivo Model A375 xenograft model
In Vitro Model Amelanotic melanoma A375 cells CVCL_0132
References
Ref 1 Targeting and pharmacology of an anti-IL13R2 antibody and antibody-drug conjugate in a melanoma xenograft model. MAbs. 2021 Jan-Dec;13(1):1958662.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.